Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Inflammation and Disability in Progressive-Onset MS
JAMA Neurology; ePub 2018 Aug 6; Hughes, et al
In progressive-onset multiple sclerosis (MS), superimposed relapses are associated with a lower risk of confirmed disability progression, according to a recent study. Researchers conducted an observational cohort study from MSBase, an international database. From 44,449 patients at time of extraction, 1,419 eligible patients (31.9%) were identified for analysis. Inclusion criteria consisted of primary progressive MS (PPMS) or progressive-relapsing MS (PRMS), adult-onset disease, and minimum data set (including ≥3 visits with disability recorded, ≥3 months between second and last visit). They found:
- Patients with PRMS were younger than those with PPMS (mean [SD] age, 46 [15] vs 51 [10] years) and demonstrated a mean lower Expanded Disability Status Scale score (mean [SD] score, 4.0 [3] vs 4.5 [2.5]) at inclusion.
- The ratio of men to women was similar in the PRMS and PPMS groups (252:301 vs 394:472).
- The overall mean (SD) age was 48 (11) years for men and 50 (10) years for women.
- Likelihood of confirmed disability progression was lower in patients with superimposed relapses (HR 0.83).
Hughes J, Jokubaitis V, Ligaresi A, et al. Association of inflammation and disability accrual in patients with progressive-onset multiple sclerosis. [Published online ahead of print August 6, 2018]. JAMA Neurology. doi:10.1001/jamaneurol.2018.2109.